Related by context. All words. (Click for frequent words.) 70 Appendices 68 See Appendix 64 Appendix B 63 Attachment 62 See Attachment 59 Appendix I. 59 Supplemental Schedule 58 APPENDIX 57 Annexure 57 attached hereto 56 Annexes 54 subparagraphs 54 subpart 54 Annexures 54 Supplementary Information 53 Refer 53 B.1 53 Appendix II 53 Addendum 53 Appendixes 53 Non GAAP reconciliations 52 Appendix 4E 52 Explanatory Notes 52 Figure 52 B.3 52 Non GAAP Measures 52 Subpart 52 ATTACHMENT 52 Rev. Proc 51 Unaudited Reconciliations 51 Exhibit 51 Supplemental Schedules 51 Explanatory notes 51 Applicability 51 Supplementary Appendix 50 Longitudinal Section 50 Appendix Table 50 Appendix 5B 50 Non GAAP Measure 50 Annex 50 A.2 49 non GAAP Measures 49 END FOOTNOTE 49 NON GAAP MEASURES 49 Glossary 49 Appendix 4D 49 USC § #c 49 subclause 49 LSA RS #:# [001] 49 § #.# [002] 49 Table 49 Supplementary Data 49 appendix 48 Paragraph 48 Supplemental Non GAAP 48 annexed hereto 48 subparagraph 48 SUPPLEMENTARY INFORMATION 48 See id 48 Ohio Adm.Code 48 Income Tax Regs 48 USC § #u 48 - -Crazyhorse 48 Section #.# [001] 48 Exh 48 -Genereaux 48 B.2 48 Condensed consolidated 48 #.#-# [005] 48 Interpretive Guidance 48 Explanatory Note 48 Drill Hole Location 47 Guidance Document 47 Subchapter 47 LENDER PROCESSING SERVICES INC. 47 K. Glossary 47 MRS § 47 Executive Summary 47 CFR § #.# [007] 47 USC § #a b 47 Schedule 47 TABLE OF CONTENTS 47 Corporate Governance Statement 47 CFR #.# [002] 47 Attached hereto 47 ITEPA 47 Financial Measures 47 GATT Article 47 FAR #.# 46 CFR #.# c 46 Item 46 USC § #a c 46 C.1 46 Statistical Tables 46 Subparagraph 46 Non GAAP Reconciliations 46 Standardized Distributable Cash 46 NJSA #:# [001] 46 Supplementary Table 46 Historical Pro Forma 46 Supplemental 46 Subtitle 46 Subsection 46 Practice Direction 46 § #B#.# [002] 46 appendices 46 ANNEXURE 46 La. RS #:# [001] 46 § #.#-# [004] 46 Content Outline 45 Regulation FD Disclosure 45 CFR #.# d 45 annexure mark 45 CFR § #.# [006] 45 La. RS #:#.# 45 Definitions 45 III.#.# 45 subsection 45 Article VIII 45 USC § #a [001] 45 C.# 45 See ARS § 45 CFR § #.# [004] 45 CFR § #.# [008] 45 Suppl 45 CFR § #.# [002] 45 Civ.R. 45 -John F. Biemeck 45 Docket Entry No. 45 condensed consolidated interim 45 RC #.# [002] 45 tabular reconciliation 45 Supplemental Figure 45 Location Map 45 ALASKA COMMUNICATIONS SYSTEMS GROUP 45 Section 45 FINANCIAL STATEMENTS 45 subsections b 45 CSR #-#.# 45 LSA RS #:# [002] 45 Endnotes 45 CFR pt 45 Pricing Supplement 45 USC § #f 45 CITES Appendix 45 Non GAAP Measurements 45 § #:# [001] 45 Ohio Adm.Code #-#-# 45 Va. Code § 45 Regulation SK 45 § #a [002] 45 Guideline 45 Measures Reconciliation 45 Paragraphs 45 Appendix VII 45 § #.#.# [002] 45 O. Reg 44 Code § #-#.# 44 Non IFRS 44 MINDRAY MEDICAL INTERNATIONAL LIMITED 44 ANNUAL REPORT 44 Continuous Disclosure 44 preambular 44 subchapter 44 Comparability 44 Non GAAP Disclosures 44 Cash Flow Statement 44 Fact Sheet 44 Proposing Release 44 Terms Companies Mentioned 44 Summarized 44 Annexure B 44 Proposed Rule 44 Condensed Consolidated 44 Subsections 44 CFR #.# [006] 44 Condensed Cash Flow 44 CFR § #.# [005] 44 AND REGULATION 44 La.RS #:# [003] 44 Crim.R. 44 ASX Listing Rule #.#A 44 Significant Transactions Affecting 44 Overview 44 Supplemental Table 44 ANNEX 44 Rev. Rul 44 corresponding reconciliations 44 Significant Accounting Policies 44 USSG § #B#.# [002] 44 REMUNERATION REPORT 44 CFR § #.# [003] 44 Contents Introduction 44 I.1 44 Add.1 44 LIST OF FIGURES 44 Segmental 44 Reconciliation Tables 44 END FOOTNOTE FOOTNOTE 44 MARPOL Annex 44 EXECUTIVE SUMMARY 44 § #-#-# b [003] 44 Capitalised terms 44 Key Topics Covered 44 NJSA #:# [002] 44 www.x cal.com 44 Items affecting comparability 44 DTR #.#.# 44 RH DONNELLEY CORPORATION 44 enclosed herewith 44 -Cedomir Jovanovic 44 Hedging Relationships 44 serovar 43 Offer Document dated 43 USGAAP 43 Recent Accounting Pronouncements 43 Non GAAP Financial 43 Diagram 43 Subsection c 43 § #a [003] 43 AFI #-# 43 section #WB 43 Vertical Restraints 43 Fig. 43 Accori North 43 - -Ascaron 43 titled SUPPLEMENTAL DISCLOSURE 43 cmt 43 IRS Publication 43 Conversion Factor 43 CFR #.# [007] 43 Regulation SX 43 § #-# [001] 43 -tiger muskies 43 Managements Discussion 43 note d' opération 43 subsection b 43 YM BIOSCIENCES INC. 43 CFR § § #.# [001] 43 #.#-# b [001] 43 subparts 43 Spleen gall bladder 43 RC #.# B [002] 43 Income Statement 43 Listing Rule #.#.# [003] 43 IV.#.# 43 DC Code § 43 II Item 9A 43 Subsection b 43 Figs. 43 ARS § #-# [001] 43 - -Lucintel 43 #A# [009] 43 Notice #-# [001] 43 LUCENT TECHNOLOGIES INC. AND 43 CFR #.# [001] 43 condensed consolidated 43 -Cullercoats 43 ORCP 43 Technical Specifications 43 NJAC #:#-#.# 43 Listing Rule #.#A 43 Domicile Australia 43 Evid.R. 43 Ref. 43 interim unaudited consolidated 43 § #A [001] 43 ASX Announcement 43 Abbreviations 43 Original Bidder Statement 43 USC § #a [002] 43 Prospectus dated 43 Tex. Admin 43 subsection h 42 Code § #.#-# [001] 42 subparagraph B 42 attached backgrounder 42 Accounting Policies 42 CFR Pt 42 INA § 42 Eur Urol 42 Appendix 4D item 42 SPECIAL BUSINESS 42 reconciles EBITDA 42 subsections 42 Amending Directive 42 Supplementary Figs 42 CFR § #.# [001] 42 CFR § § #.# [002] 42 § #-#.# [001] 42 FAR Subpart 42 CFR #.# [008] 42 #.#-# [020] 42 Supplementary Material 42 Sensitivity Analysis 42 Subsection d 42 BIOTRONIK GmbH 42 Summary Table 42 See IRS Publication 42 explanatory notes 42 Annex VI 42 Supplemental Information 42 footnotes 42 Rule #h 42 DEFINITIONS 42 SAMREC 42 cytochrome b 42 Article 42 CHIQUITA BRANDS INTERNATIONAL INC. 42 § #-# [004] 42 Brief Profile 42 CFR #.# [005] 42 NJSA #:# C 42 Article XXIV 42 www.EAminerals.com 42 #.# 5T 42 Cautionary Notes 42 www.eurasianminerals.com 42 W#CRB 42 Regulation G 42 Comparative 42 MMLP Quarterly Report 42 USC § #b [002] 42 See Restatement Second 42 endnote 42 Docket Number 42 Supplementary Prospectus 42 Sunpower Corp Class 42 Recommendation 42 IRC § § 42 Acknowledgements 42 Adjusted Non GAAP 42 2n = 42 ASX Listing Rules 42 ASX Announcements 42 Non Gaap 42 #.#-# b [002] 42 phospholipase 42 KRS #.# [003] 42 INDUSTRY DEFINITION Industry 42 entitled Caution Regarding 42 CFR § 42 § #A [002] 42 GenBank accession 42 paragraph 42 VSA § 42 nonGAAP 42 See Annexure 42 Exposure Draft 42 subsection c 42 subsection f 42 Reclassified 42 Cautionary Statement Regarding 41 attached herewith 41 COGE Handbook 41 Types 41 annexure 41 Item 9A 41 Sections 41 #-#.# [014] 41 CICA Accounting Guideline 41 Regulatory Developments 41 please refer 41 USC § #b [001] 41 ICAO Annex 41 multivitamins vitamin 41 RS #:# [002] 41 WESTWOOD ONE INC. SUPPLEMENTAL 41 Freeport Mcmoran C 41 USC § #A 41 Please refer 41 Figure 3a 41 Apolipoprotein 41 R. #:#-# 41 Proposed Revisions 41 USC § #a [003] 41 Revised Guidelines 41 NJSA 2C :5 41 Footnote Table 41 § #:# [002] 41 Unaudited Pro Forma 41 RSA #:# [002] 41 Business Spectator glossary 41 Disclosure Requirements 41 Reproduced Record RR 41 USSG § #G#.# b 41 S/#/# 41 NF Summary 41 DOSAGE AND ADMINISTRATION 41 Reference Manual 41 § #G#.# 41 Multilateral Instrument 41 GLOSSARY 41 NASDAQ OMX Copenhagen 41 Subgroup 41 A1 A2 A3 41 HTSUS 41 annexure marked 41 #.#.#.# [011] 41 Docket Nos. 41 NUREG 41 POLYCOM INC. GAAP 41 Agenda Item 41 § #.# [001] 41 Remuneration Report 41 pdf 41 Data Deficient 41 http:/www.mpegla.com 41 Customs Tariff Act 41 3GPP W CDMA 41 SEBI ICDR Regulations 41 § #-#-# [002] 41 Unaudited Reconciliation 41 Repl. 41 MEMO/#/# [002] 41 Consolidated Statement 41 NJSA #A 41 Okla. Stat 41 A2 A3 41 Scheme Booklet 41 Annex Notification 41 GASB Issues 41 IPCC TAR 41 Histopathologic 41 [004] 41 Sec. 41 MB Docket 41 adjusted unlevered free 41 IFRS IFRS 41 * Reclassified 41 CICA Handbook 41 Certain comparative 41 Contracts § 41 Unaudited Condensed Consolidated 41 wedge Hole TC# 41 Accounting Standard AASB 41 Consolidated Cash Flows 41 Amending Chapter 41 Interrogatory No. 41 www.magsilver.com 41 Clause 41 Explanatory Statement 41 Listing Application 41 Proposed Regulations 41 SEMPRA ENERGY Table 41 Supplementary Fig 41 STATE STREET CORPORATION 41 Physica 41 See USSG § #B#.# 41 § § #-# [003] 41 non gaap 41 Conversion Ratio 41 Supplemental Circular 41 § #-#.# [002] 41 Distributable Cash 41 Download PDF 41 FINAL REPORT 41 Significant intercepts 41 CORPORATE DIRECTORY 41 Schedule UTP 41 FIRST DATA CORPORATION 41 J Pediatr Orthop 41 END FOOTNOTE * 41 Internal Revenue Code § 40 #.#A [006] 40 THE WARNACO GROUP INC. 40 V/# 40 tropicalis 40 Comparative Figures 40 § § 40 B# [004] 40 #g# 2 40 #ppm U 40 2A 2B 40 Rule #B 40 Pro forma Adjusted EBITDA 40 www.sedar.ca 40 LSA CCP art 40 Maj. Op 40 § #.# [004] 40 Legislative Decree 40 App.R. 40 #-#.# [016] 40 CITES Appendix II 40 Sentencing Guidelines Manual 40 explanatory memoranda 40 AFEP MEDEF 40 Appendix 4D Half 40 No. #R Consolidation 40 II.#.# 40 HBeAg positive chronic hepatitis 40 CLASSIFICATION OF 40 Topics Covered Executive 40 w illus 40 Competent Persons Report 40 Largo website www.largoresources.com 40 column headings 40 CFR #.#b 40 Segmented Results 40 Legal #.# 40 USC #a [001] 40 GRI G3 40 TCA § #-#-# [003] 40 Adjusted FIFO EBITDA 40 Supp. 40 Comparative Analysis 40 § #-#-#.# 40 thereof Controls 40 captioned Adjusted EBITDA 40 Significant assay 40 RSA #:# [001] 40 MMLP Annual Report 40 Company Periodic Filings 40 Listing Requirements 40 DUNS Number 40 Continuous Disclosure Policy 40 IAS IFRS 40 Supplement 40 Notice #-# [002] 40 DFARS #.#-# 40 Eur Heart 40 datasheet 40 QWEST COMMUNICATIONS INTERNATIONAL INC. 40 CFR § § 40 ORS #B.# 40 condensed consolidated balance sheets 40 -Peter Van Keuren 40 Figure 1a 40 Explanatory Memorandum 40 ARS § #-# [002] 40 B1 B2 40 Mineral Resource Estimation 40 PHOTO EDITORS 40 Suppl. 40 #.# subd [004] 40 Monograph 40 § #.#-# [007] 40 Referenced 40 FINANCIAL MEASURES 40 DISCUSSION AND POSSIBLE APPROVAL 40 Critical Accounting Policies 40 Deskbook 40 ATCF 40 D1 D2 40 condensed consolidated financial 40 Annual Audited Consolidated 40 DFARS 40 -Shinning Crown Holdings 40 .W. McNichols 40 Competitive Landscape 40 Factsheet 40 Whitepapers 40 Emissions Trading Directive 40 #:#-# [002] 40 unaudited Condensed Consolidated 40 FERC Stats 40 www.newsweb.no 40 p.# [001] 40 summary 40 Bakoudou Zone 40 Interim Consolidated 40 A/# [002] 40 Revenue Procedure 40 Counterparty Criteria 40 Summarised 40 § #L#.# b 40 phylogeny 40 Reconciliations 40 E.2 40 ARS § 40 Consolidated Financial 40 condensed consolidated statements 40 Figure 2a 40 NYCRR § 40 Non GAAP 40 Significant Items Affecting 40 NJAC 6A 40 ICCD COP 40 OCGA § #-#-# [002] 40 TEXT OMITTED FROM SOURCE 40 FIDELITY NATIONAL INFORMATION SERVICES 40 Conforms 40 Qty 40 EUROCAE 40 § #.# [005] 40 www.queenston.ca 40 Miscellaneous Deductions 40 USCS § 40 Financial Statements 40 HARRIS CORPORATION FY'# 40 Phylogenetic 40 Submission Guidelines 40 A/#/# [001] 40 unaudited interim 40 comparable GAAP 40 Art. 40 5TH CIR 40 Normalized Earnings 40 subseries 40 IFRIC 40 Selected GAAP Measures 40 -Meadowbrook Parkway 40 FIFO EBITDA 40 CCH Pension Plan 40 :# [004] 40 § #-#-# [004] 40 Half Yearly Report 40 Backgrounder 40 Offeror Representations 40 CONSOLIDATED FINANCIAL STATEMENTS 40 #S #S [003] 40 SEC Regulation SX 40 CFR #.# b 40 SEE ATTACHED 40 + Despatch 40 CREATE TABLE 40 Segmental Analysis 40 -Amos Harel Haaretz Correspondent 40 5A 5B 40 directive #/#/EC [002] 40 MANAGEMENT DISCUSSION AND ANALYSIS 40 VBER 40 At#g# 40 xsl template 40 Tabular 40 Histologic 40 Regulation 40 Schedules #D 40 1.a. 40 www.duluthmetals.com 40 NJSA 2C :2 40 ILCS #/#-# [001] 40 Recent Past Perspective 40 LIST OF TABLES Table 40 FIND OUT MORE 40 Azimut Qualified Person 40 Product Monograph 39 Management Proxy Circular 39 #a #b [002] 39 FASB Statement 39 www.dendrite.com 39 Information Circular dated 39 Adanac Moly Corp. 39 § #-#-# [003] 39 regulations thereunder 39 LIST OF TABLES 39 cystatin 39 Items Impacting Comparability 39 #/#/EEC [002] 39 #.# [042] 39 § #.#.# [001] 39 accompanying Explanatory Memorandum 39 Regulations Governing 39 Zootaxa 39 sakazakii 39 L# L# [002] 39 Offer Booklet 39 #.#-# [017] 39 Slip Op 39 unaudited consolidated balance sheets 39 -Matisse Radical Invention 39 Rating Methodology 39 Brief Introduction 39 La. RS #:# [003] 39 #.#-# Offeror Representations 39 Hedging Relationships AcG 39 FINANCIAL INFORMATION 39 AND SUBSIDIARIES SEGMENT REPORTING 39 INTRODUCTION 39 #/#/EC [002] 39 Habitats Directive 39 -Epidemiol 39 Reference Guide 39 Nike Inc Cl 39 Key Findings 39 Tranches C 39 Reference Document 39 Downing Protected VCT 39 Generally Accepted 39 Eligibility Criteria 39 www.fraserinstitute.ca 39 Risk Factors 39 FOIA Exemption 39 :# [002] 39 DHC consolidated 39 Implementation Specification 39 Medicare Physician Fee 39 § #G#.# b 39 NRS #.# [002] 39 Attachments 39 Quantification 39 NYCRR 39 Arizona Revised Statutes 39 GAAP NON GAAP 39 Teleostei 39 FAR clauses 39 Complete corrected 39 SAFE HARBOUR 39 CIM definitions 39 Colorado Revised Statutes 39 Supplementary 39 Pro Rata 39 NJSA 2A #A 39 Chapter 6D 39 Descriptive 39 unaudited Consolidated Statement 39 Adjusted EBITDAX 39 galactosidase 39 #.# subdivision [004] 39 suppl. 39 VGS = 39 EXPLANATORY MEMORANDUM 39 Implementing Regulations 39 Disclosure Controls 39 Philosophical Transactions 39 4A 4B 39 DJ AIGCI Handbook 39 accompanying condensed consolidated 39 WAC #-#-# 39 phylogenetic 39 hereto 39 Critical Accounting 39 subtotals 39 www.omxgroup.com 39 Article ISI ChemPort 39 Summary 39 Recommended Practice 39 Nationality Act INA 39 EARNINGS MEASURES 39 -PPH 39 PHILIP MORRIS INTERNATIONAL INC. 39 OF NON GAAP MEASURES 39 FASB ASC 39 SYSC 39 adjusted ebitda 39 Companies Mentioned 39 NASD Marketplace Rule 39 #:# [013] 39 Normalized EBIT 39 reftel 39 G# [003] 39 WA7BNM contest websites 39 items affecting comparability 39 Mortgagee Letter 39 Ark. Sup 39 REAL ESTATE BUSINESS 39 #b c 39 KRS #A.# [002] 39 hardiness zones 39 § #A [003] 39 http:/www.smartstox.com 39 Annexin 39 ADV Part 39 RISKS AND UNCERTAINTIES 39 ESA# 39 Form 39 -Richard Gitlen 39 Annotated 39 hugin.info/#/R/#/#.pdf [001] 39 orthologs 39 #B.# [002] 39 - + [020] 39 Stapling Proposal 39 Cash Flow Margin 39 USC § § #e 39 Reply Br 39 SEDAR www.SEDAR.com 39 Condensed Statement 39 section #.#.# 39 dated #.#.# [002] 39 FASB ASC #-# 39 Simplified Prospectus 39 Condensed Consolidated Interim 39 Consolidated Cash Flow 39 Article ChemPort 39 REGARDING NON GAAP 39 #/#-page 39 Kottelat 39 Multivariate 39 E.1 39 Docket ID 39 SEC Rule #g# 39 REYNOLDS AMERICAN 39 Adjusted EBIT 39 suppl 39 #.#.#R 39 Corporate Governance Principles 39 Competent Person Report 39 -Tomine 39 ref. 39 NON GAAP 39 holotype 39 SUMMARY OF QUARTERLY RESULTS 39 Tables 39 Summary RECONCILIATION OF 39 DREF Bulletin 39 #:#-# [014] 39 RC #.# B [001] 39 L imited 39 Ariz. Sess 39 FINANCIAL OVERVIEW 39 Core Hand Held 39 SAMREC Code 39 Saprolite mafic intrusive 39 WpUG 39 IRC § 39 Material Assumptions 39 M anagement 39 OCGA § #-#-#.# 39 Reviewed Reviewed 39 Product Definitions 39 Items Affecting Comparability 39 FFO + GOS 39 EOE M F 39 Note en Réponse 39 NJSA #A #A 39 Interval m 39 Annex VII 39 Conclusions 39 Capital Disclosures 39 Pregnancy Category 39 HRS § #-# [001] 39 Figure 1A 39 Article XXI 39 Section #-#-# [007] 39 La.RS #:# [002] 39 SECTION 39 USC #d 39 EDWARDS LIFESCIENCES CORPORATION 39 #A #B [002] 39 RC #.# [001] 39 vitamins B# 39 NAICS code 39 heading ITEM 1A 39 archaeal 39 IC § #-# 39 Clarifications 39 Amended Disclosure Statement 39 Capital Requirements Directive 39 MIL DTL 39 subtopic 39 USSG § #D#.# 39 reconciles GAAP 39 #a #a [003] 39 #a [004] 39 iLounge Rating 39 schematic diagram 39 CFR Parts 39 MIL DTL # 39 s#A [002] 39 www.alexanderbaldwin.com 39 MARPOL 39 1B substructures 39 Segmented 39 FAR #.#-# Offeror Representations 39 Fig. 2a 39 Accounting Standards Codification 39 GAAP Adj 39 Noncritical 39 -analyst Suki Cooper 39 Continued Airworthiness 39 AMR CORPORATION CONSOLIDATED 39 subsection d 39 Pa.RAP 39 Clinical Practice Guideline 39 Eligibility Requirements 39 § #-#-# b [001] 39 DCID 6 39 FABP 39 INTERIM FINANCIAL STATEMENTS 38 Article XIII 38 #.pdf [001] 38 REACH SVHC 38 unaudited Consolidated Statements 38 ACCOUNTING POLICIES 38 TIA EIA 38 FAR Subpart #.# 38 Cautionary Factors 38 Macroeconomic Indicators CHAPTER 38 SUPPLEMENTAL OPERATING INFORMATION 38 #K#.# 38 Haplogroup 38 AND CONTROLLED ENTITIES 38 WG2 38 REMUNERATION REPORT AUDITED 38 Three Month Periods 38 Disclosure Requirement 38 Factors Impacting 38 NON GAAP FINANCIAL MEASURES 38 - Non GAAP [031] 38 TRIPs Agreement 38 C.4 38 NJSA #:#-# [004] 38 explanatory memorandum 38 § #-#.# [003] 38 COMAR 38 DFAR 38 [006] 38 hnRNP 38 Appendix 4E Preliminary 38 Recent Developments 38 FR # [001] 38 FINANCIAL REPORT 38 USSG § 38 vide Notification No. 38 STOCK BASED COMPENSATION EXPENSE 38 Pharmacopoeia USP 38 fig. S3 38 CICA Section 38 Conceptual Framework 38 Gov.Bar R. V 38 NCGS § 38 Compensation Disclosure 38 Antoine Yassa P.Geo 38 EXPLANATORY STATEMENT 38 Section #-#-# [005] 38 hereinabove 38 Certifications Commercial 38 Hr'g Tr 38 Audited 38 NIST SP# 38 Netop Solutions 38 Keywords MARKETS HONGKONG STOCKS 38 Diagnostic Radiopharmaceuticals 38 USC #a [002] 38 D.1 38 #.html [002] 38 Cautionary Information 38 clade 38 1A 1B 38 Pro Forma Results 38 Öko Institut 38 Accounting Guideline 38 unaudited consolidated interim 38 PHOENIX TECHNOLOGIES LTD 38 cholerae 38 Pa.CS § 38 e fficiency 38 Statistics DGCI & 38 Investment Considerations 38 B.# [001] 38 ADOPTION OF THE 38 RCW #.#A.# 38 Amdt 38 AQUARIUS PLATINUM LIMITED 38 User Guide 38 Worksheet 38 :4 38 Consultation Document 38 spud #-#-# drlg [003] 38 fig. 38 Cetomimidae 38 #.# subd [003] 38 RSMo 38 Proposed Rulemaking NPR 38 Operating Segments 38 Position Paper 38 #/#/# Appendix 3B [003] 38 Wireless Legal Footnote 38 Womack Mariah Carey 38 Competitive Scenario 38 COGEH 38 Propagation Forecast Bulletin 38 overleaf 38 ID nWLF# 38 www.dejour.com 38 CORPORATE GOVERNANCE STATEMENT 38 financialstatements 38 ISO IEC #A 38 MFRS 38 Mineral Resource estimation 38 GAILES Sgle Stab Div 38 SEK -#.# -#.# [002] 38 Mineralized Material 38 IEC #-#-# [003] 38 Dent Res 38 Hunting Regulations 38 Recreational Fishing Regulations 38 LSA RS 38 AS NZS #:# 38 RC #.# F 38 Synthetic Fuel 38 Tables Charts 38 QST page 38 Blakes Bulletin 38 § #B#.# b 38 Preferential Issues 38 filetype pdf 38 Eq. 38 Computed 38 Board FASB Accounting 38 Appendix 1A 38 Goanikontes Anomaly 38 folic acid vitamins 38 Fig.1 38 EDGAR Online via COMTEX 38 Colo. Sess 38 - - Adjusted [002] 38 s.# [001]